123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction

Παρόμοια τεκμήρια

• 123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
  ανά: Cornelissen, B, κ.ά.
  Έκδοση: (2004)
• Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
  ανά: Cornelissen, B, κ.ά.
  Έκδοση: (2005)
• Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
  ανά: Oltenfreiter, R, κ.ά.
  Έκδοση: (2004)
• In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
  ανά: Cornelissen, B, κ.ά.
  Έκδοση: (2005)
• A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
  ανά: Cornelissen, B, κ.ά.
  Έκδοση: (2003)